Showing results (371-380 of 1,945) with videos related to

Sort By:
Pageof 195
RMD Open|August 31, 2023
Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitisJuergen Braun, Joachim Sieper
RMD Open|August 28, 2023
Maternal and neonatal antibody levels on pertussis vaccination in pregnant women on immune-modulating therapy for rheumatic diseaseNafise Ghalandari, Maarten M Immink, Esther Röder, et al.
RMD Open|August 31, 2023
Children with extended oligoarticular and polyarticular juvenile idiopathic arthritis have alterations in B and T follicular cell subsets in peripheral blood and a cytokine profile sustaining B cell activationCatarina Tomé, Filipa Oliveira-Ramos, Raquel Campanilho-Marques, et al.
RMD Open|August 31, 2023
Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort studyMichaela Koehm, Maximilian Klippstein, Stephanie Dauth, et al.
RMD Open|August 30, 2023
Antibiotic exposure in prenatal and early life and risk of juvenile idiopathic arthritis: a nationwide register-based cohort studySigrid Hestetun, Svend Andersen, Helga Sanner, et al.
RMD Open|August 21, 2023
Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysisEric Morand, Josef S Smolen, Michelle Petri, et al.
RMD Open|August 21, 2023
Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseasesEduardo José Ferreira Santos, Bayram Farisogullari, Emma Dures, et al.
RMD Open|August 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Yuki Etani, Yuichi Maeda, et al.
RMD Open|January 10, 2024
Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkersHelena Port, Frederik Christiansen, Signe Holm Nielsen, et al.
RMD Open|January 10, 2024
What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experimentRieke Alten, Juan Carlos Nieto-Gonzalez, Peggy Jacques, et al.
Pageof 195